Future liver remnant hypertrophy rate in portal vein embolization before left trisectionectomy: a retrospective cohort study

2021 ◽  
Author(s):  
Yasuyuki Onishi ◽  
Hiroyoshi Isoda ◽  
Tsuyoshi Ohno ◽  
Hironori Shimizu ◽  
Kotaro Shimada ◽  
...  
Keyword(s):  
Cohort Study ◽  
Portal Vein ◽  
Portal Vein Embolization ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Future Liver Remnant ◽  
Liver Remnant ◽  
Left Trisectionectomy

scholarly journals Segment 4 occlusion in portal vein embolization increase future liver remnant hypertrophy – A Scandinavian cohort study

2020 ◽  
Vol 75 ◽  
pp. 60-65 ◽  
Author(s):  
Bergthor Björnsson ◽  
Kristina Hasselgren ◽  
Bård Røsok ◽  
Peter Noergaard Larsen ◽  
Jozef Urdzik ◽  
...  
Keyword(s):  
Cohort Study ◽  
Portal Vein ◽  
Portal Vein Embolization ◽  
Future Liver Remnant ◽  
Liver Remnant

scholarly journals Oncological Outcomes after Liver Venous Deprivation for Colorectal Liver Metastases: A Single Center Experience

Cancers ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 200
Author(s):  
Salah Khayat ◽  
Gianluca Cassese ◽  
François Quenet ◽  
Christophe Cassinotto ◽  
Eric Assenat ◽  
...  
Keyword(s):  
Portal Vein ◽  
Liver Metastases ◽  
Portal Vein Embolization ◽  
Colorectal Liver Metastases ◽  
Future Liver Remnant ◽  
Small Sample ◽  
Right Hepatectomy ◽  
Liver Remnant ◽  
Oncological Outcomes ◽  
Extended Right Hepatectomy

Colorectal liver metastases (CRLM) are the major cause of death in patients with colorectal cancer (CRC). The cornerstone treatment of CRLM is surgical resection. Post-operative morbidity and mortality are mainly linked to an inadequate future liver remnant (FLR). Nowadays preoperative portal vein embolization (PVE) is the most widely performed technique to increase the size of the future liver remnant (FLR) before major hepatectomies. One method recently proposed to increase the FLR is liver venous deprivation (LVD), but its oncological impact is still unknown. The aim of this study is to report first short- and long-term oncological outcomes after LVD in patients undergoing right (or extended right) hepatectomy for CRLM. Seventeen consecutive patients undergoing LVD between July 2015 and May 2020 before an (extended) right hepatectomy were retrospectively analyzed from an institutional database. Post-operative and follow-up data were analyzed and reported. Primary outcomes were 1-year and 3-year overall survival (OS) and hepatic recurrence (HR). Postoperative complications occurred in 8 patients (47%). No deaths occurred after surgery. HR occurred in 9 patients (52.9%). 1-year and 3-year OS were 87% (95% confidence interval [CI]: ±16%) and 60.3%, respectively (95% CI: ±23%). Median Disease-Free Survival (DFS) was 6 months (CI 95%: 4.7–7.2). With all the limitations of a retrospective study with a small sample size, LVD showed similar oncological outcomes compared to literature reports for Portal Vein Embolization (PVE).

scholarly journals Portal Vein Thrombosis in Adult Omani Patients: A Retrospective Cohort Study

2017 ◽  
Vol 32 (6) ◽  
pp. 522-527
Author(s):  
Khalid Al Hashmi ◽  
Lamya Al Aamri ◽  
Sulayma Al Lamki ◽  
Anil Pathare
Keyword(s):  
Cohort Study ◽  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Vein Thrombosis

scholarly journals Portal Vein Embolization: Radiological Findings Predicting Future Liver Remnant Hypertrophy

2020 ◽  
Vol 214 (3) ◽  
pp. 687-693
Author(s):  
Shigeshi Kohno ◽  
Hiroyoshi Isoda ◽  
Ayako Ono ◽  
Akihiro Furuta ◽  
Kojiro Taura ◽  
...  
Keyword(s):  
Portal Vein ◽  
Portal Vein Embolization ◽  
Future Liver Remnant ◽  
Radiological Findings ◽  
Liver Remnant
Sign in / Sign up

Export Citation Format

Share Document